Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672516 · ClinicalTrials.gov registry record
Management of Bleeding Following Cardiopulmonary Bypass
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 43
- Enrollment target
NCT00672516: Completed study, sponsored by University of Minnesota.
NCT00672516 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672516 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
We believe ongoing bleeding during complex cardiac surgery can be accurately measured and that administration of a specific blood product replacement strategy designed to optimally slow or stop the bleeding can be followed by the during the operation. Patients at risk of significant bleeding after complex cardiac surgery will be approached to allow their operation to be watched by study personnel to see if ongoing blood loss can be accurately measured and to see how quickly a prescribed, standardized blood product replacement protocol to control the bleeding does slow or stop the bleeding. Permission to review the medical record to see if bleeding risk features can be identified and permission to follow the patient after surgery to see how they recover is also requested.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-05 |
What the finished NCT00672516 record still lists
NCT00672516 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00672516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00672516 about?
NCT00672516 is a clinical study titled "Management of Bleeding Following Cardiopulmonary Bypass". We believe ongoing bleeding during complex cardiac surgery can be accurately measured and that administration of a specific blood product replacement strategy designed to optimally slow or stop the bleeding can be followed by the during the operation. Patients at risk of significant bleeding after ...
What is the current status of trial NCT00672516?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2008-04. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT00672516?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia